27
total announcements
SYNGENE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹15,976 Cr
P/E (TTM)
72.4
P/E (Forward)
37.1
EPS (TTM)
₹5.49
52W Low
₹344.45
52W High
₹678.95
Dividend Yield
0.32%
Beta
0.07
Price / Book
3.3
Debt / Equity
9.5
Revenue (TTM)
₹3,600 Cr
Gross Margin
68.00%
Operating Margin
3.90%
Syngene International Ltd
Syngene International Ltd held its 33rd Annual General Meeting on July 29, 2026, through video conferencing, where 117 members were present. The meeting approved the audited financial statements for the year ended March 31, 2026, and declared a final dividend of Rs. 1.25 per equity share.
Syngene International Ltd
Syngene International Ltd announced the resignation of Independent Director Mr. Kush Parmar, effective July 29, 2026, due to increasing commitments in the USA and inability to devote sufficient time to the Company.
Syngene International Ltd
Syngene International Limited announced its Q1 FY27 results, with revenue from operations at Rs. 736 Cr and operating EBITDA at Rs. 91 Cr. The company's performance was impacted by the lack of offtake from a major biologics client and forex hedge loss. Despite this, the company maintains a strong balance sheet and financial discipline, which provides flexibility to invest in strategic priorities.
Syngene International Ltd
Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a profit before tax of Rs. (192) million and a profit for the period of Rs. (90) million. The results also include a net loss of Rs. (135) million from exceptional items.
Syngene International Ltd
Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 6,630 million and a net profit of Rs. 21 million. The company's consolidated revenue from operations was Rs. 7,360 million, with a net profit of Rs. 90 million.
Syngene International Ltd
Syngene International Ltd has announced a conference call with analysts and investors to discuss Q1 FY 2026-27 financial results on July 30, 2026.
Syngene International Ltd
Syngene International Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Mirae Asset Mutual Fund.